Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adverse drug reaction reporting by patients in the Netherlands: three years of experience.
de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K. de Langen J, et al. Among authors: van hunsel f, van grootheest k. Drug Saf. 2008;31(6):515-24. doi: 10.2165/00002018-200831060-00006. Drug Saf. 2008. PMID: 18484785
Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.
van Hunsel F, Passier A, van Grootheest K. van Hunsel F, et al. Among authors: van grootheest k. Br J Clin Pharmacol. 2009 May;67(5):558-64. doi: 10.1111/j.1365-2125.2009.03400.x. Epub 2009 Feb 26. Br J Clin Pharmacol. 2009. PMID: 19552751 Free PMC article.
Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins.
van Hunsel F, van Puijenbroek E, de Jong-van den Berg L, van Grootheest K. van Hunsel F, et al. Among authors: van puijenbroek e, van grootheest k. Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):26-32. doi: 10.1002/pds.1865. Pharmacoepidemiol Drug Saf. 2010. PMID: 19953500
What motivates patients to report an adverse drug reaction?
van Hunsel FP, ten Berge EA, Borgsteede SD, van Grootheest K. van Hunsel FP, et al. Among authors: van grootheest k. Ann Pharmacother. 2010 May;44(5):936-7. doi: 10.1345/aph.1M632. Epub 2010 Apr 13. Ann Pharmacother. 2010. PMID: 20388861 No abstract available.
Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.
van Hunsel F, van der Welle C, Passier A, van Puijenbroek E, van Grootheest K. van Hunsel F, et al. Among authors: van der welle c, van puijenbroek e, van grootheest k. Eur J Clin Pharmacol. 2010 Nov;66(11):1143-50. doi: 10.1007/s00228-010-0865-7. Epub 2010 Jul 24. Eur J Clin Pharmacol. 2010. PMID: 20658130 Free PMC article.
Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.
Härmark L, van Hunsel F, Hak E, van Grootheest K. Härmark L, et al. Among authors: van hunsel f, van grootheest k. Vaccine. 2011 Feb 24;29(10):1941-7. doi: 10.1016/j.vaccine.2010.12.123. Epub 2011 Jan 12. Vaccine. 2011. PMID: 21236235
The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study.
van Hunsel F, Talsma A, van Puijenbroek E, de Jong-van den Berg L, van Grootheest K. van Hunsel F, et al. Among authors: van puijenbroek e, van grootheest k. Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):286-91. doi: 10.1002/pds.2092. Epub 2010 Dec 28. Pharmacoepidemiol Drug Saf. 2011. PMID: 21351310
[Adverse drug reactions of a slimming product contaminated with sibutramine].
van Hunsel F, van Grootheest K. van Hunsel F, et al. Among authors: van grootheest k. Ned Tijdschr Geneeskd. 2011;155(42):A3695. Ned Tijdschr Geneeskd. 2011. PMID: 22027464 Dutch.
Experiences with adverse drug reaction reporting by patients: an 11-country survey.
van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K. van Hunsel F, et al. Among authors: van grootheest k. Drug Saf. 2012 Jan 1;35(1):45-60. doi: 10.2165/11594320-000000000-00000. Drug Saf. 2012. PMID: 22149419 Review.
73 results
Jump to page
Feedback